Sagimet Biosciences Inc. (SGMT)
NASDAQ · Healthcare
Sagimet Biosciences Inc. Shareholder Equity 2023–2023
Sagimet Biosciences Inc. annual/quarterly shareholder equity history from 2023 to 2023. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Sagimet Biosciences Inc. shareholder equity for the quarter ending December 31, 2023 were 91.1M.
- Sagimet Biosciences Inc. shareholder equity for 2023 were 91.1M.
Shareholder Equity
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Sagimet Biosciences Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2023 | $91 |
| Sagimet Biosciences Inc. Quarterly Shareholder Equity (Millions of US $) | |
|---|---|
| 2023-12-31 | $91 |
Sagimet Biosciences Inc. Shareholder Equity — FAQ
Sagimet Biosciences Inc. (SGMT) shareholder equity over the last 1 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see SGMT's shareholder equity history?
The chart and table above show Sagimet Biosciences Inc.'s shareholder equity by year and by quarter, including the growth rate.